You can buy or sell Bellus Health and other stocks, options, ETFs, and crypto commission-free!
BELLUS Health Inc. Common Shares, also called Bellus Health, is a biopharmaceutical development company which engages in the research and development of novel therapeutics for the treatment of chronic cough and other hypersensitisation disorders. Read More Its product, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.
52 Week High
52 Week Low
— per share
Expected Nov 12, Pre-Market